May 2 – 5, 2026
Chicago, IL
Booth #607
Discover How Artivion is Driving Innovation With an Aortic Focus
Lunch
Symposium
Lunch Symposium
Saturday, May 2, 2026
12:00 PM – 1:00 PM CT
Breakout 6, E351
Add event to calendar
Expanding the Aortic Surgeon’s Toolkit
from the Valve to the Arch
The Next Frontier of AVR in Younger Patients
Moderator
S. Christopher Malaisrie, MD
Northwestern University
Chicago, IL
Evolving Strategies in Acute Type A Dissection:
Integrating AMDS™ into Practice
John Trahanas, MD
Vanderbilt University
Nashville, TN
Nexus® Endovascular Arch Solution:
Design Insights and One-Year Outcomes
Himanshu Patel, MD
University of Michigan
Ann Arbor, MI
This Industry Symposium will be held in conjunction with the Annual Meeting of the American Association for Thoracic Surgery (AATS). It is not part of the official AATS Scientific Program. Continuing Medical Education (CME) credit for this activity is not offered by AATS.
MLENG2044.000 (2026-03)
AMDS is RX Only: Humanitarian Use Device. Authorized by Federal Law for use in the treatment of acute DeBakey Type I Aortic Dissection. The effectiveness of this device for this use has not been demonstrated. Refer to the device’s Instructions for Use for indications, contraindications, warnings, precautions and possible complications. NEXUS is a Investigational Device – Limited by United States law to investigational use. Notice of Availability – Physician Referrals. Outside of the United States device availability is subject to local regulations and guidelines.
Take a Closer Look at our Aortic Focus
AMDS™
ON-X® AORTIC
BioGlue®
